F7

  • Official Full Name

    coagulation factor VII (serum prothrombin conversion accelerator)

  • Overview

    Factor VII (formerly known as proconvertin) is one of the proteins that causes blood to clot in the coagulation cascade. It is an enzyme (EC 3.4.21.21) of the serine protease class. A recombinant form of human factor VIIa (NovoSeven, eptacog alfa [activated]) has U.S. Food and Drug Administration approval for uncontrolled bleeding in hemophilia patients. It is often used unlicensed in severe uncontrollable bleeding, although there has been safety concerns.
  • Synonyms

    F7; coagulation factor VII; SPCA; eptacog alfa; proconvertin; OTTHUMP00000018733; OTTHUMP00000018734; FVII coagulation protein; serum prothrombin conversion accelerator; factor VII;

  • Recombinant Proteins
  • Cell & Tissue Lysates
  • Transfected Stable Cell Lines
  • Native Proteins
  • Protein Pre-coupled Magnetic Beads
  • Therapeutic Proteins
  • Antibody
  • Cattle
  • Chicken
  • Human
  • Mouse
  • Rabbit
  • Rat
  • Rhesus Macaque
  • Zebrafish
  • BHK
  • CHO
  • E.coli
  • Hamster Kidney
  • HEK293
  • HEK293T
  • Human Cell
  • Human Plasma
  • In Vitro Cell Free System
  • Mammalian Cell
  • Mammalian cells
  • Rabbit
  • Wheat Germ
  • Yeast
  • GST
  • His
  • Fc
  • Avi
  • SUMO
  • T7
  • Myc
  • DDK
  • Non
Species Cat.# Product name Source (Host) Tag Protein Length Price
Human F7-720H Active Recombinant Human F7 Protein, His-tagged Mammalian cells His Ala39-Pro444
Human F7-3908H Active Recombinant Human F7 protein, His-tagged HEK293 His Ala 61 - Pro 466
Human F7-124H Recombinant Human F7 BHK Non
Human F7-28711TH Recombinant Human F7 Non
Human F7-3622H Recombinant Human F7 Protein, GST-tagged Wheat Germ GST
Human F7-1911H Recombinant Human F7 protein, His-tagged E.coli His Ala334~Arg452
Human F7-3907H Recombinant Human F7 protein, His-tagged HEK293 His Met1-Pro444
Human F7-1973HCL Recombinant Human F7 cell lysate Human Cell Non
Human F7-24H Human Blood Coagulation Factor VIIa Reference standard Non
Human F7-530H Recombinant Human F7 Protein, Myc/DDK-tagged, C13 and N15-labeled HEK293T Myc&DDK
Human F7-39H Human Factor VII Reference standard Non
Human F7-5303H Native Human Coagulation Factor VII (serum prothrombin conversion accelerator) Human Plasma Non
Human F7-959H Recombinant Human F7 Protein, MYC/DDK-tagged HEK293 Myc&DDK
Human F7-2880H Recombinant Human F7 protein, His-SUMO-tagged E.coli His&SUMO 61-212aa
Human F7-2893H-B Recombinant Human F7 Protein Pre-coupled Magnetic Beads HEK293
Human F7-4500HF Recombinant Full Length Human F7 Protein, GST-tagged In Vitro Cell Free System GST 444 amino acids
Human F7-5400H Recombinant Human F7 protein, His-tagged Yeast His 61-212aa
Human F7-2308H Recombinant Human F7 Protein (Ala334-Arg452), His tagged E.coli His Ala334-Arg452
Human F7-2893H Recombinant Human F7 Protein, His (Fc)-Avi-tagged HEK293 His&Fc&Avi
Human F7-2602H Recombinant Human F7 protein(71-210 aa), C-His-tagged E.coli His 71-210 aa
Human F7-P042H Recombinant Human F7 therapeutic protein(Coagulation factor VIIa Recombinant Human) Hamster Kidney Non 406 aa
Mouse F7-828M Active Recombinant Mouse F7 Protein, His-tagged CHO His Met1-Leu446
Mouse F7-1912M Recombinant Mouse F7 protein, His-tagged E.coli His Ala42~Lys169
Mouse F7-2206M Active Recombinant Mouse F7 protein(Met1-Leu446), His-tagged CHO His Met1-Leu446
Mouse F7-8662M Recombinant Mouse F7, His-tagged Human Cell His Met1-Leu446
Mouse F7-001MCL Recombinant Mouse F7 cell lysate CHO Non
Mouse CAB11538RM Rabbit Anti-Mouse FVII protein Monoclonal Antibody Rabbit Non
Mouse F7-1000M Recombinant Mouse F7 Protein, MYC/DDK-tagged HEK293T Myc&DDK
Rat F7-1914R Recombinant Rat F7 protein, His-tagged E.coli His Ala315~Asp433
Rat F7-1913R Recombinant Rat F7 protein, His & GST-tagged E.coli His&GST Ala42~Lys169
Rat F7-2180R Recombinant Rat F7 Protein Mammalian Cell His
Rat F7-911R Recombinant Rat F7 Protein, His&GST-tagged E.coli His&GST Ile194-Leu446
Rat F7-1837R Recombinant Rat F7 Protein, His (Fc)-Avi-tagged HEK293 His&Fc&Avi
Rat F7-1837R-B Recombinant Rat F7 Protein Pre-coupled Magnetic Beads HEK293
Rabbit F7-1915R Recombinant Rabbit F7 protein, His & T7-tagged E.coli His&T7 Ala40~Arg191
Cattle F7-1910C Recombinant Cattle F7 protein, His & GST-tagged E.coli His&GST Ile193~Pro447
Rhesus Macaque F7-1532R Recombinant Rhesus monkey F7 Protein, His-tagged Mammalian Cell His
Rhesus Macaque F7-1357R Recombinant Rhesus Macaque F7 Protein, His (Fc)-Avi-tagged HEK293 His&Fc&Avi
Rhesus Macaque F7-1357R-B Recombinant Rhesus Macaque F7 Protein Pre-coupled Magnetic Beads HEK293
Zebrafish F7-9330Z Recombinant Zebrafish F7 Mammalian Cell His
Chicken F7-6012C Recombinant Chicken F7 Mammalian Cell His
  • Background
  • Quality Guarantee
  • Case Study
  • Involved Pathway
  • Protein Function
  • Interacting Protein
  • Other Resource
F7-7.jpg

Fig1. Schema showing factor VII activation, activity and inhibition. (Francesco Bernardi, 2021)

What is F7 Protein?

Factor VII, or F7 protein, is crucial for blood clotting. Made mainly in the liver, it jumps into action when there's an injury, partnering with tissue factor to kickstart clot formation. This process turns fibrinogen into fibrin, which forms the clot. The F7 gene on chromosome 13 guides its production, and any mutation here can lead to a rare bleeding disorder known as Factor VII deficiency. Folks with this condition might experience anything from nosebleeds to severe internal bleeding. Interestingly, Factor VII's activity relies on vitamin K, and medications like warfarin can reduce its levels by affecting its synthesis in the liver.

What is the Function of F7 Protein?

F7 protein is like a key player in our body's way of stopping cuts from bleeding too much. It's kind of like the starter in a relay race for blood clotting. When we get hurt, F7 changes into its active form, F7a, especially when it meets up with another protein called tissue factor, which shows up at the injury site. Once F7a and tissue factor join forces, they get other clotting factors, like X and IX, moving in the right direction. This whole process ends up turning prothrombin into thrombin, which helps make a strong fibrin clot. That clot is like a plug that stops the bleeding and helps our body heal the wound. If F7 isn't working right, we might have trouble with bleeding, which shows just how important it is for keeping our blood balanced.

F7 Related Signaling Pathway

Factor VII, or F7, is vital in the coagulation cascade, helping in blood clotting. When there's damage to blood vessels, F7 becomes activated and partners with tissue factor (TF) to set off a chain of events that eventually form a blood clot. This activation of F7 is part of the extrinsic pathway, a rapid-response mechanism to minimize bleeding by converting prothrombin to thrombin. Thrombin then transforms fibrinogen into fibrin, weaving a stable clot to safeguard the wound. Beyond its primary role, F7's interactions can influence inflammation and even cell signaling in various pathological conditions.

F7 Related Diseases

Factor VII, or F7, is connected to a variety of blood-related diseases primarily due to its integral role in clotting. If there's too little F7, it can cause bleeding disorders since the blood doesn't clot properly. Conversely, too much F7 activity might lead to excessive clotting, which can result in conditions like thrombosis. This delicate balance makes F7 an important factor in maintaining normal circulatory health and preventing both bleeding and clotting complications.

Bioapplications of F7

Recombinant F7 protein finds extensive use across research and industrial sectors because of its key role in exploring blood clotting processes. In scientific studies, it is a significant instrument for dissecting clotting mechanisms and formulating treatments for bleeding conditions. The protein is also instrumental in devising diagnostic tests to assess bleeding dangers and is used in the production of pharmaceuticals to ensure the safety and effectiveness of blood-thinning drugs. Offering a dependable and uniform protein source, recombinant F7 boosts progress in medical research and biotechnology applications.

High Purity

SDS-PAGE (F7-3908H).jpg

Fig1. SDS-PAGE (F7-3908H)

.

SDS-PAGE (F7-3622H).jpg

Fig2. SDS-PAGE (F7-3622H)

Case Study 1: Sarai Pongjantarasatian, 2019

Human mesenchymal stem cells (hMSCs) can transform into liver-like cells, which might make them useful for making biopharmaceuticals. Our team developed an immortalized hepatocyte-like cell line from these stem cells, which shows some liver-specific features. We checked if these cells could produce coagulation proteins and found that they could generate a small amount of human factor VII (FVII) using a lentiviral system, releasing about 22 ng/mL into a culture medium. The coagulation activity of FVII from these cells was nearly the same as that from HEK293T cells, as shown by testing. This is the first indication that these cells can produce FVII, showcasing a distinct quality of liver cells.

F7-1.jpg

Fig1. FVII levels secreted in culture media supernatant.

F7-2.jpg

Fig2. FVII coagulant activity from each cell line determined by chromogenic assay.

Case Study 2: Prafull S Gandhi, 2024

Dealing with serious bleeding disorders like Glanzmann thrombasthenia (GT) can be tough since there's no standard preventive treatment available. Right now, people handle severe bleeding with blood transfusions or by frequently giving recombinant activated factor VII (rFVIIa) intravenously. Researchers have come up with HMB-001, a bispecific antibody that attaches to the body's natural FVIIa, aiming to direct it to areas of blood vessel damage using a special receptor found on activated platelets. In studies with healthy nonhuman primates, HMB-001 extended the lifespan of FVIIa, leading to its build-up. Tests on mice and ex vivo models of GT showed that this antibody boosts FVIIa's effectiveness by targeting it to activated platelets, promoting clotting. These findings suggest that HMB-001 could become a new subcutaneous treatment option, potentially preventing bleeding episodes in GT and similar disorders with less frequent dosing.

F7-3.jpg

Fig3. rFVIIa-equivalent activity was measured in PRP from healthy controls supplemented with d-RGDW to obtain GT-like platelets.

F7-4.jpg

Fig4. Fibrin-dependent platelet pseudoaggregation was measured in washed platelets from healthy donors supplemented with d-RGDW.

F7 involved in several pathways and played different roles in them. We selected most pathways F7 participated on our site, such as Complement and coagulation cascades, which may be useful for your reference. Also, other proteins which involved in the same pathway with F7 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.

Pathway Name Pathway Related Protein
Complement and coagulation cascadesPLAT;TFPI;PLAUR;C4A;F11;SERPIND1;SERPINA1A;Serpina1b;CD59

F7 has several biochemical functions, for example, calcium ion binding, glycoprotein binding, protein binding. Some of the functions are cooperated with other proteins, some of the functions could acted by F7 itself. We selected most functions F7 had, and list some proteins which have the same functions with F7. You can find most of the proteins on our site.

Function Related Protein
calcium ion bindingPCDH1G3;ACTN3A;DGKG;CHP2;PKD2L1;CD69;DGKA;S100A11;MGP
glycoprotein bindingCALR;AZGP1;VWF;PLAT;TFR2;ERBB2;TGFB1;B2M;ITGB2
protein bindingTBC1D10C;MED28;ZBTB49;PCK2;FAP;DTX3;CST3;HORMAD1;RECK
receptor bindingNRG3;PEX14;WNT11R;CADM2A;HLA-F;ASIP;PVR;CSK;ANGPTL1
serine-type endopeptidase activityF9B;HTRA4;PRSS57;TPP1;PRSS59.1;GZMA;TMPRSS2;KLK1B22;CFI
serine-type peptidase activityDPP7;PRSS28;TMPRSS12;GZME;MCPT1;ELA3L;PRSS44;PLAUB;TMPRSS11B

F7 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with F7 here. Most of them are supplied by our site. Hope this information will be useful for your research of F7.

F3; capsh_ade05; DMWD; USP49; UIMC1; IKBKG; RCHY1; ALB; BECN1; SLX4; GABARAPL1

Gene Family

IL TGF Kinesins (KIF) Cytokines

Research Area

Related articles

Guo, HJ; Cruz-Munoz, ME; et al. Immune Cell Inhibition by SLAMF7 Is Mediated by a Mechanism Requiring Src Kinases, CD45, and SHIP-1 That Is Defective in Multiple Myeloma Cells. MOLECULAR AND CELLULAR BIOLOGY 35:41-51(2015).
Balasa, B; Yun, R; et al. Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-alpha pathways. CANCER IMMUNOLOGY IMMUNOTHERAPY 64:61-73(2015).
  • Reviews
  • Q&As

Customer Reviews (3)

Write a review
Reviews
05/18/2022

    Quick turnaround—this product arrived swiftly, facilitating our research.

    10/03/2019

      Exceptional quality and precision—our lab relies on this protein consistently.

      05/29/2018

        Invaluable assistance from customer service—professional and responsive.

        Q&As (5)

        Ask a question
        How does F7 contribute to hemostasis, and what is its role in preventing excessive bleeding? 04/02/2021

        Factor VII's role in the coagulation cascade ensures rapid initiation of clot formation, preventing excessive bleeding and contributing to hemostasis.

        Discuss the role of F7 in the extrinsic pathway of blood coagulation. 07/20/2020

        Factor VII is a key player in the extrinsic pathway, where it forms a complex with tissue factor to activate factor X, initiating the cascade leading to thrombin generation.

        What are the mechanisms of F7 activation, and how is it regulated at the molecular level? 01/15/2019

        Factor VII is activated through a proteolytic cleavage, converting it into its active form (VIIa). This activation is regulated by tissue factor and other coagulation factors.

        Explain the biochemical basis of F7 deficiency and its implications for bleeding disorders. 11/05/2018

        F7 deficiency results in impaired blood clotting, leading to a bleeding disorder known as coagulation factor VII deficiency. This condition can manifest in varying degrees of severity.

        Explain the role of F7 in the coagulation cascade and blood clot formation. 09/28/2018

        Factor VII is activated to its enzymatically active form (factor VIIa) and initiates the coagulation cascade by activating factor X, ultimately leading to the formation of a stable blood clot.

        Ask a Question for All F7 Products

        Required fields are marked with *

        My Review for All F7 Products

        Required fields are marked with *

        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /
        • Service lnquiry:

        Stay Updated on the Latest Bioscience Trends